Obeso JA - Search Results

1

A Cortical Pathogenic Theory of Parkinson's Disease.

Foffani G, Obeso JA. Foffani G, et al. Among authors: obeso ja. Neuron. 2018 Sep 19;99(6):1116-1128. doi: 10.1016/j.neuron.2018.07.028. Neuron. 2018. PMID: 30236282 Review.

2

Motor complications in Parkinson's disease: Striatal molecular and electrophysiological mechanisms of dyskinesias.

Picconi B, Hernández LF, Obeso JA, Calabresi P. Picconi B, et al. Among authors: obeso ja. Mov Disord. 2018 Jul;33(6):867-876. doi: 10.1002/mds.27261. Epub 2017 Dec 8. Mov Disord. 2018. PMID: 29219207 Review.

3

What would Dr. James Parkinson think today? The 21st Annual Congress of the International Parkinson's disease and movement disorders society.

Obeso JA, Trenkwalder C. Obeso JA, et al. Mov Disord. 2017 Jul;32(7):951-954. doi: 10.1002/mds.27108. Mov Disord. 2017. PMID: 28712120 No abstract available.

4

Striatal activation by optogenetics induces dyskinesias in the 6-hydroxydopamine rat model of Parkinson disease.

F Hernández L, Castela I, Ruiz-DeDiego I, Obeso JA, Moratalla R. F Hernández L, et al. Among authors: obeso ja. Mov Disord. 2017 Apr;32(4):530-537. doi: 10.1002/mds.26947. Epub 2017 Mar 3. Mov Disord. 2017. PMID: 28256089

5

What Would Dr. James Parkinson Think Today? I. The Role of Functional Neurosurgery for Parkinson's Disease.

Hariz M, Obeso JA. Hariz M, et al. Among authors: obeso ja. Mov Disord. 2017 Jan;32(1):2-4. doi: 10.1002/mds.26911. Mov Disord. 2017. PMID: 28124429 No abstract available.

6

Functions of the basal ganglia-paradox or no paradox?

Crossman AR, Obeso JA. Crossman AR, et al. Among authors: obeso ja. Mov Disord. 2016 Aug;31(8):1120-1. doi: 10.1002/mds.26745. Mov Disord. 2016. PMID: 27506637 No abstract available.

7

Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy.

Obeso JA, Stamelou M, Goetz CG, Poewe W, Lang AE, Weintraub D, Burn D, Halliday GM, Bezard E, Przedborski S, Lehericy S, Brooks DJ, Rothwell JC, Hallett M, DeLong MR, Marras C, Tanner CM, Ross GW, Langston JW, Klein C, Bonifati V, Jankovic J, Lozano AM, Deuschl G, Bergman H, Tolosa E, Rodriguez-Violante M, Fahn S, Postuma RB, Berg D, Marek K, Standaert DG, Surmeier DJ, Olanow CW, Kordower JH, Calabresi P, Schapira AHV, Stoessl AJ. Obeso JA, et al. Mov Disord. 2017 Sep;32(9):1264-1310. doi: 10.1002/mds.27115. Mov Disord. 2017. PMID: 28887905 Free PMC article. Review.

8

Impulse control disorders and levodopa-induced dyskinesias in Parkinson's disease: an update.

Voon V, Napier TC, Frank MJ, Sgambato-Faure V, Grace AA, Rodriguez-Oroz M, Obeso J, Bezard E, Fernagut PO. Voon V, et al. Lancet Neurol. 2017 Mar;16(3):238-250. doi: 10.1016/S1474-4422(17)30004-2. Epub 2017 Feb 15. Lancet Neurol. 2017. PMID: 28229895 Review.

9

Influence of microRNA deregulation on chaperone-mediated autophagy and α-synuclein pathology in Parkinson's disease.

Alvarez-Erviti L, Seow Y, Schapira AH, Rodriguez-Oroz MC, Obeso JA, Cooper JM. Alvarez-Erviti L, et al. Among authors: obeso ja. Cell Death Dis. 2013 Mar 14;4(3):e545. doi: 10.1038/cddis.2013.73. Cell Death Dis. 2013. PMID: 23492776 Free PMC article.

10

Subthalamic nucleus-mediated excitotoxicity in Parkinson's disease: a target for neuroprotection.

Rodriguez MC, Obeso JA, Olanow CW. Rodriguez MC, et al. Among authors: obeso ja. Ann Neurol. 1998 Sep;44(3 Suppl 1):S175-88. doi: 10.1002/ana.410440726. Ann Neurol. 1998. PMID: 9749591 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results